Chief Executive Officer
United States of America
As Chief Executive Officer, Steve oversees the strategy, vision and growth plan for SynteractHCR. His role includes augmenting best practices, expanding new services and furthering geographic reach to best serve our innovative pharma and biotech customers. A seasoned industry executive, Steve has more than 26 years of CRO and pharma/biotech industry experience. He has led both small and large companies, directing strategy across all facets of Phase I-IV clinical research, including operations, business development, technology and acquisitions and integrations. Previously, he was Executive Vice President at ERT, having come to ERT through its acquisition of Exco InTouch in December 2016. As President and COO of Exco InTouch, Steve managed all aspects of operational delivery and technology development. While at ERT, he managed a leading product line, which provided an integrated data and analytics platform. Prior to Exco InTouch, Steve served as Executive Vice President for Clinical Informatics and Late Phase Services at PRA Health Sciences for over 8 years. He has also held senior roles at INC Research and Quintiles.
Contract research organization, supporting clinical trials, supporting pharmaceutical, biotechnology and medical device companies in all phases of clinical development